FDA draft guidance aims to help sponsors develop drugs for radiation exposure
Regulatory NewsJoanne S. Eglovitch
ComplianceNorth AmericaPharmaceuticalsQuality Assurance and ControlRegulatory Intelligence/PolicyRegulatory NewsJoanne S. EglovitchComplianceNorth AmericaPharmaceuticalsQuality Assurance and ControlRegulatory Intelligence/Policy